Noguchi, Shinsuke
,
Nakaseko, Chiaki
Nishiwaki, Kaichi
Ogasawara, Hitoshi
Ohishi, Kohshi
Tokuhira, Michihide
Noguchi, Masaaki
Kimura, Hideo
Handa, Hiroshi
Mitani, Kinuko
Miura, Masatomo
Wakita, Hisashi
Takahashi, Naoto http://orcid.org/0000-0002-6758-3787
Funding for this research was provided by:
Novartis
Article History
Received: 14 February 2018
Revised: 23 April 2018
Accepted: 24 April 2018
First Online: 30 April 2018
Conflict of interest
: N.T received grants from Novartis Pharmaceuticals, during the conduct of the study; grants and personal fees from Novartis Pharmaceuticals, grants and personal fees from Otsuka, grants and personal fees from Pfizer, personal fees from Bristol-Myers Squibb, outside the submitted work; C.N received personal fees from Novartis, grants and personal fees from Bristol-Myers Squibb, grants and personal fees from Pfizer, grants and personal fees from Takeda pharmaceuticals, grants and personal fees from Kyowa Hakko Kirin, grants and personal fees from Otsuka Pharmaceutical, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Chugai Pharmaceutical, grants and personal fees from Asahi Kasei Pharma, grants and personal fees from Shionogi, personal fees from Shire, personal fees from Jannsen, personal fees from Celgene, outside the submitted work; K.N received grants from Zenyaku Kogyo Company, Limited, grants from Chugai Pharmaceutical, grants from Novartis Pharma K.K., grants from Kyowa Hakko Kirin Co, Ltd, grants from Nippon Shinyaku Co, Ltd, outside the submitted work; M.T. received personal fees from Bristol-Myers Squib, personal fees from Pfizer, outside the submitted work; K.M received grants from Kyowa Hakko Kirin Co. Ltd., grants from Chugai Pharmaceutical Co. Ltd., grants from Takeda Pharmaceutical Co. Ltd., grants from Novartis Pharma K. K., personal fees from Kyowa Hakko Kirin Co. Ltd., personal fees from Celgene Co., personal fees from Pfizer Inc., personal fees from Alexion Pharmaceuticals Inc., personal fees from BML Inc., personal fees from Shire Japan K.K., personal fees from Bristol-Myers Squibb K.K., personal fees from Abbvie Inc., personal fees from Mochida Pharmaceutical Co. Ltd., personal fees from Novartis Pharma K. K., personal fees from Takeda Pharmaceutical Co. Ltd., personal fees from Kyowa Hakko Kirin Co. Ltd., personal fees from Ono Pharmaceutical Co. Ltd., personal fees from Nippon Shinyaku Co. Ltd., outside the submitted work. The other authors declare that they have no conflicts of interest.